Clinical Trial Update: Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya®

View source ↗

Summary

Post-marketing surveillance study evaluating long-term use of Sogroya for adult growth hormone deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Sogroya (somapacitan)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Adult Growth Hormone Deficiency | Status: ACTIVE_NOT_RECRUITING